Latest Insider Transactions at Ptc Therapeutics, Inc. (PTCT)
This section provides a real-time view of insider transactions for Ptc Therapeutics, Inc. (PTCT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PTC THERAPEUTICS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PTC THERAPEUTICS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 05
2023
|
Alethia Young |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+30.61%
|
-
|
|
Jan 05
2023
|
Jerome B Zeldis |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+27.59%
|
-
|
|
Jan 05
2023
|
Allan Steven Jacobson |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+24.47%
|
-
|
|
Jan 05
2023
|
Stephanie Okey |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+40.54%
|
-
|
|
Jan 05
2023
|
Mary L. Smith |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+28.96%
|
-
|
|
Oct 18
2022
|
Mark Elliott Boulding EXEC. VP AND CLO |
SELL
Open market or private sale
|
Direct |
299
-0.24%
|
$16,445
$55.25 P/Share
|
|
Oct 18
2022
|
Mark Elliott Boulding EXEC. VP AND CLO |
BUY
Exercise of conversion of derivative security
|
Direct |
299
+0.24%
|
$8,970
$30.86 P/Share
|
|
Oct 17
2022
|
Mark Elliott Boulding EXEC. VP AND CLO |
SELL
Open market or private sale
|
Direct |
6,602
-4.9%
|
$363,110
$55.0 P/Share
|
|
Oct 17
2022
|
Mark Elliott Boulding EXEC. VP AND CLO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,602
+4.49%
|
$198,060
$30.86 P/Share
|
|
Sep 20
2022
|
Mark Elliott Boulding EXEC. VP AND CLO |
SELL
Open market or private sale
|
Direct |
1,176
-0.95%
|
$64,680
$55.0 P/Share
|
|
Sep 20
2022
|
Mark Elliott Boulding EXEC. VP AND CLO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,176
+0.94%
|
$35,280
$30.86 P/Share
|
|
Aug 09
2022
|
Stephanie Okey |
SELL
Open market or private sale
|
Direct |
2,296
-55.15%
|
$117,096
$51.62 P/Share
|
|
Jun 09
2022
|
Dawn Svoronos |
SELL
Open market or private sale
|
Direct |
738
-2.48%
|
$19,926
$27.2 P/Share
|
|
Jun 09
2022
|
Alethia Young |
BUY
Grant, award, or other acquisition
|
Direct |
5,067
+38.46%
|
-
|
|
Jun 07
2022
|
Stuart Walter Peltz CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Indirect |
407
-1.05%
|
$10,582
$26.83 P/Share
|
|
Apr 19
2022
|
Eric Pauwels CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
822
-1.62%
|
$34,524
$42.52 P/Share
|
|
Apr 19
2022
|
Matthew B. Klein CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
897
-1.56%
|
$37,674
$42.52 P/Share
|
|
Apr 14
2022
|
Stuart Walter Peltz CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Indirect |
82
-0.21%
|
$3,690
$45.28 P/Share
|
|
Apr 13
2022
|
Mark Elliott Boulding EXEC. VP AND CLO |
SELL
Open market or private sale
|
Direct |
2,276
-3.59%
|
$102,420
$45.17 P/Share
|
|
Apr 13
2022
|
Mark Elliott Boulding EXEC. VP AND CLO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,276
+3.47%
|
$25,036
$11.23 P/Share
|
|
Apr 05
2022
|
Mark Elliott Boulding EXEC. VP AND CLO |
SELL
Open market or private sale
|
Direct |
5
-0.01%
|
$225
$45.0 P/Share
|
|
Apr 05
2022
|
Mark Elliott Boulding EXEC. VP AND CLO |
BUY
Exercise of conversion of derivative security
|
Direct |
5
+0.01%
|
$55
$11.23 P/Share
|
|
Mar 31
2022
|
Emily Luisa Hill CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,910
-21.28%
|
$292,670
$37.78 P/Share
|
|
Feb 10
2022
|
Mark Elliott Boulding EXEC. VP AND CLO |
SELL
Open market or private sale
|
Direct |
17,935
-12.0%
|
$807,075
$45.03 P/Share
|
|
Feb 10
2022
|
Mark Elliott Boulding EXEC. VP AND CLO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,935
+10.21%
|
$251,090
$14.62 P/Share
|
|
Feb 02
2022
|
Christine Marie Utter SVP, CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
707
-2.71%
|
$28,280
$40.38 P/Share
|
|
Feb 01
2022
|
Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER |
SELL
Open market or private sale
|
Indirect |
27
-1.1%
|
$1,080
$40.0 P/Share
|
|
Feb 01
2022
|
Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER |
SELL
Open market or private sale
|
Direct |
605
-1.22%
|
$24,200
$40.0 P/Share
|
|
Feb 01
2022
|
Mark Elliott Boulding EXEC. VP AND CLO |
SELL
Open market or private sale
|
Direct |
779
-1.26%
|
$31,160
$40.0 P/Share
|
|
Feb 01
2022
|
Emily Luisa Hill CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
553
-1.47%
|
$22,120
$40.0 P/Share
|
|
Feb 01
2022
|
Eric Pauwels CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
367
-0.72%
|
$14,680
$40.0 P/Share
|
|
Feb 01
2022
|
Stuart Walter Peltz CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Indirect |
282
-0.72%
|
$11,280
$40.0 P/Share
|
|
Feb 01
2022
|
Stuart Walter Peltz CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
1,961
-1.6%
|
$78,440
$40.0 P/Share
|
|
Feb 01
2022
|
Christine Marie Utter SVP, CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
313
-1.18%
|
$12,520
$40.0 P/Share
|
|
Jan 25
2022
|
Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER |
SELL
Open market or private sale
|
Indirect |
43
-1.73%
|
$1,677
$39.31 P/Share
|
|
Jan 25
2022
|
Emily Luisa Hill CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
211
-0.56%
|
$8,229
$39.31 P/Share
|
|
Jan 25
2022
|
Eric Pauwels CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
359
-0.7%
|
$14,001
$39.31 P/Share
|
|
Jan 25
2022
|
Stuart Walter Peltz CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Indirect |
330
-0.84%
|
$12,870
$39.31 P/Share
|
|
Jan 18
2022
|
Christine Marie Utter SVP, CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
11,428
-16.29%
|
$491,404
$43.75 P/Share
|
|
Jan 18
2022
|
Christine Marie Utter SVP, CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+21.54%
|
$180,000
$18.01 P/Share
|
|
Jan 07
2022
|
Glenn Jr Md Phd Steele |
BUY
Grant, award, or other acquisition
|
Direct |
3,200
+32.99%
|
-
|
|
Jan 07
2022
|
David P Southwell |
BUY
Grant, award, or other acquisition
|
Direct |
3,200
+32.99%
|
-
|
|
Jan 07
2022
|
Jerome B Zeldis |
BUY
Grant, award, or other acquisition
|
Direct |
3,200
+32.99%
|
-
|
|
Jan 07
2022
|
Stephanie Okey |
BUY
Grant, award, or other acquisition
|
Direct |
3,200
+43.46%
|
-
|
|
Jan 07
2022
|
Emma Reeve |
BUY
Grant, award, or other acquisition
|
Direct |
3,200
+29.83%
|
-
|
|
Jan 07
2022
|
Allan Steven Jacobson |
BUY
Grant, award, or other acquisition
|
Direct |
3,200
+27.71%
|
-
|
|
Jan 07
2022
|
Michael Schmertzler |
BUY
Grant, award, or other acquisition
|
Direct |
6,400
+5.51%
|
-
|
|
Jan 07
2022
|
Dawn Svoronos |
BUY
Grant, award, or other acquisition
|
Direct |
3,200
+9.71%
|
-
|
|
Jan 07
2022
|
Dawn Svoronos |
SELL
Open market or private sale
|
Direct |
510
-1.88%
|
$19,380
$38.52 P/Share
|
|
Jan 07
2022
|
Mary L. Smith |
BUY
Grant, award, or other acquisition
|
Direct |
3,200
+35.5%
|
-
|